American biopharmaceutical firm Sirnaomics Inc. has raised US$22 million in a series C2 round of financing led by CR-CP Life Sciences Fund, a Hong Kong-based joint venture between Asian conglomerates China Resources Group and Charoen Pokphand Group, according to a statement released on Saturday. The new investment brought the total capital raised in its series […]

Hong Kong’s CR-CP Life Science Fund Leads $22M Series C2 Round In US Biotech Firm comes originally from China Money Network. All Rights Reserved.